|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
(+ 0 more)
162 a.a.
|
 |
|
|
|
|
|
|
|
(+ 0 more)
96 a.a.
|
 |
|
|
|
|
|
|
|
(+ 0 more)
158 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Inhibition of caspase-2 by a designed ankyrin repeat protein (darpin)
|
|
Structure:
|
 |
Caspase-2. Chain: a, c, e, g, i, k. Fragment: residues 167-333. Caspase-2. Chain: b, d, f, h, j, l. Fragment: residues 348-452. Engineered: yes. Caspase-2. Chain: p, q, r, s, t, u.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Strain: bl21(de3). Gene: casp2. Gene: casp2
|
|
Resolution:
|
 |
|
3.24Å
|
R-factor:
|
0.262
|
R-free:
|
0.305
|
|
|
Authors:
|
 |
H.Roschitzki Voser,C.Briand,G.Capitani,M.G.Gruetter
|
Key ref:
|
 |
A.Schweizer
et al.
(2007).
Inhibition of Caspase-2 by a Designed Ankyrin Repeat Protein: Specificity, Structure, and Inhibition Mechanism.
Structure,
15,
625-636.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-Mar-07
|
Release date:
|
22-May-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P42575
(CASP2_HUMAN) -
Caspase-2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
452 a.a.
162 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E, F, G, H, I, J, K, L:
E.C.3.4.22.55
- caspase-2.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
15:625-636
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Inhibition of Caspase-2 by a Designed Ankyrin Repeat Protein: Specificity, Structure, and Inhibition Mechanism.
|
|
A.Schweizer,
H.Roschitzki-Voser,
P.Amstutz,
C.Briand,
M.Gulotti-Georgieva,
E.Prenosil,
H.K.Binz,
G.Capitani,
A.Baici,
A.Pl?ckthun,
M.G.Gr?tter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Specific and potent caspase inhibitors are indispensable for the dissection of
the intricate pathways leading to apoptosis. We selected a designed ankyrin
repeat protein (DARPin) from a combinatorial library that inhibits caspase-2 in
vitro with a subnanomolar inhibition constant and, in contrast to the peptidic
caspase inhibitors, with very high specificity for this particular caspase. The
crystal structure of this inhibitor (AR_F8) in complex with caspase-2 reveals
the molecular basis for the specificity and, together with kinetic analyses, the
allosteric mechanism of inhibition. The structure also shows a conformation of
the active site that can be exploited for the design of inhibitory compounds.
AR_F8 is a specific inhibitor of an initiator caspase and has the potential to
help identify the function of caspase-2 in the complex biological apoptotic
signaling network.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Stereo Representation of the Structure of the
Caspase-2/AR_F8 Complex Caspase-2 is shown in dark blue (α
subunit) and light blue (β subunit), and AR_F8 is shown in
salmon. AR_F8 is bound to the back side of the
active-site-forming loop 381 (see Figure 5C) of each caspase-2
monomer. Termini and loops affected by binding of AR_F8 are
shown in red. The active-site cysteine (Cys285) and the
intersubunit disulfide bond are shown in yellow.
|
 |
Figure 3.
Figure 3. Molecular Interactions between AR_F8 and Caspase-2
Stereo representation of the caspase-2/AR_F8 interface
rotated vert,
similar 90° from the standard orientation, viewed from the
back plane of the caspase, displaying hydrogen bonds (green,
dotted lines) and hydrophobic interactions. Interacting residues
of AR_F8 are shown in red; those of caspase-2 are shown in blue.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(2007,
15,
625-636)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.Monroe,
G.Sennhauser,
M.A.Seeger,
C.Briand,
and
M.G.Grütter
(2011).
Designed ankyrin repeat protein binders for the crystallization of AcrB: plasticity of the dominant interface.
|
| |
J Struct Biol,
174,
269-281.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.J.Farady,
and
C.S.Craik
(2010).
Mechanisms of macromolecular protease inhibitors.
|
| |
Chembiochem,
11,
2341-2346.
|
 |
|
|
|
|
 |
D.X.Hou,
and
T.Kumamoto
(2010).
Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling.
|
| |
Antioxid Redox Signal,
13,
691-719.
|
 |
|
|
|
|
 |
J.M.Lipchock,
and
J.P.Loria
(2010).
Nanometer propagation of millisecond motions in V-type allostery.
|
| |
Structure,
18,
1596-1607.
|
 |
|
|
|
|
 |
M.Drag,
and
G.S.Salvesen
(2010).
Emerging principles in protease-based drug discovery.
|
| |
Nat Rev Drug Discov,
9,
690-701.
|
 |
|
|
|
|
 |
C.F.Cervantes,
P.R.Markwick,
S.C.Sue,
J.A.McCammon,
H.J.Dyson,
and
E.A.Komives
(2009).
Functional dynamics of the folded ankyrin repeats of IkappaB alpha revealed by nuclear magnetic resonance.
|
| |
Biochemistry,
48,
8023-8031.
|
 |
|
|
|
|
 |
D.Veesler,
B.Dreier,
S.Blangy,
J.Lichière,
D.Tremblay,
S.Moineau,
S.Spinelli,
M.Tegoni,
A.Plückthun,
V.Campanacci,
and
C.Cambillau
(2009).
Crystal structure and function of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode.
|
| |
J Biol Chem,
284,
30718-30726.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Gao,
S.S.Sidhu,
and
J.A.Wells
(2009).
Two-state selection of conformation-specific antibodies.
|
| |
Proc Natl Acad Sci U S A,
106,
3071-3076.
|
 |
|
|
|
|
 |
M.Gebauer,
and
A.Skerra
(2009).
Engineered protein scaffolds as next-generation antibody therapeutics.
|
| |
Curr Opin Chem Biol,
13,
245-255.
|
 |
|
|
|
|
 |
P.Milovnik,
D.Ferrari,
C.A.Sarkar,
and
A.Plückthun
(2009).
Selection and characterization of DARPins specific for the neurotensin receptor 1.
|
| |
Protein Eng Des Sel,
22,
357-366.
|
 |
|
|
|
|
 |
S.Koide,
and
S.S.Sidhu
(2009).
The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins.
|
| |
ACS Chem Biol,
4,
325-334.
|
 |
|
|
|
|
 |
S.Koide
(2009).
Engineering of recombinant crystallization chaperones.
|
| |
Curr Opin Struct Biol,
19,
449-457.
|
 |
|
|
|
|
 |
T.Kitevska,
D.M.Spencer,
and
C.J.Hawkins
(2009).
Caspase-2: controversial killer or checkpoint controller?
|
| |
Apoptosis,
14,
829-848.
|
 |
|
|
|
|
 |
A.Schweizer,
P.Rusert,
L.Berlinger,
C.R.Ruprecht,
A.Mann,
S.Corthésy,
S.G.Turville,
M.Aravantinou,
M.Fischer,
M.Robbiani,
P.Amstutz,
and
A.Trkola
(2008).
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics.
|
| |
PLoS Pathog,
4,
e1000109.
|
 |
|
|
|
|
 |
D.Barrick,
D.U.Ferreiro,
and
E.A.Komives
(2008).
Folding landscapes of ankyrin repeat proteins: experiments meet theory.
|
| |
Curr Opin Struct Biol,
18,
27-34.
|
 |
|
|
|
|
 |
D.Frey,
T.Huber,
A.Plückthun,
and
M.G.Grütter
(2008).
Structure of the recombinant antibody Fab fragment f3p4.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
636-643.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Grueninger,
N.Treiber,
M.O.Ziegler,
J.W.Koetter,
M.S.Schulze,
and
G.E.Schulz
(2008).
Designed protein-protein association.
|
| |
Science,
319,
206-209.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Kloss,
N.Courtemanche,
and
D.Barrick
(2008).
Repeat-protein folding: new insights into origins of cooperativity, stability, and topology.
|
| |
Arch Biochem Biophys,
469,
83-99.
|
 |
|
|
|
|
 |
K.Anestål,
S.Prast-Nielsen,
N.Cenas,
and
E.S.Arnér
(2008).
Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.
|
| |
PLoS ONE,
3,
e1846.
|
 |
|
|
|
|
 |
M.T.Stumpp,
H.K.Binz,
and
P.Amstutz
(2008).
DARPins: a new generation of protein therapeutics.
|
| |
Drug Discov Today,
13,
695-701.
|
 |
|
|
|
|
 |
P.Hauske,
C.Ottmann,
M.Meltzer,
M.Ehrmann,
and
M.Kaiser
(2008).
Allosteric regulation of proteases.
|
| |
Chembiochem,
9,
2920-2928.
|
 |
|
|
|
|
 |
T.M.Bandeiras,
R.C.Hillig,
P.M.Matias,
U.Eberspaecher,
J.Fanghänel,
M.Thomaz,
S.Miranda,
K.Crusius,
V.Pütter,
P.Amstutz,
M.Gulotti-Georgieva,
H.K.Binz,
C.Holz,
A.A.Schmitz,
C.Lang,
P.Donner,
U.Egner,
M.A.Carrondo,
and
B.Müller-Tiemann
(2008).
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
339-353.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Tereshko,
S.Uysal,
A.Koide,
K.Margalef,
S.Koide,
and
A.A.Kossiakoff
(2008).
Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold.
|
| |
Protein Sci,
17,
1175-1187.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.S.Salvesen,
and
S.J.Riedl
(2007).
Caspase inhibition, specifically.
|
| |
Structure,
15,
513-514.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|